PGC-1α, glucose metabolism and type 2 diabetes mellitus

145Citations
Citations of this article
209Readers
Mendeley users who have this article in their library.

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by glucose metabolic disturbance. A number of transcription factors and coactivators are involved in this process. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α) is an important transcription coactivator regulating cellular energy metabolism. Accumulating evidence has indicated that PGC-1α is involved in the regulation of T2DM. Therefore, a better understanding of the roles of PGC-1α may shed light on more efficient therapeutic strategies. Here, we review the most recent progress on PGC-1α and discuss its regulatory network in major glucose metabolic tissues such as the liver, skeletal muscle, pancreas and kidney. The significant associations between PGC-1α polymorphisms and T2DM are also discussed in this review.

Cite

CITATION STYLE

APA

Wu, H., Deng, X., Shi, Y., Su, Y., Wei, J., & Duan, H. (2016). PGC-1α, glucose metabolism and type 2 diabetes mellitus. Journal of Endocrinology. BioScientifica Ltd. https://doi.org/10.1530/JOE-16-0021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free